Although the overexpression of XBP1, the regulator of the UPR pathway, was not detected in our proteomic analysis, our pathway analysis showed that XBP1 might be a potential therapeutic target for keloids because most proteins that were overexpressed in keloids can be regulated by XBP1 (Figure 4C). This evidence concerns the gene XBP1 and keloid.